Tradestie Institutional Equity Comparison Engine

ERAS vs CAPR โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ERAS Overall Edge

ERAS Captures Institutional Edge (2โ€“2 Pillars ยท 6โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Erasca, Inc. Common Stock (ERAS) driven by superior Growth & Margin, Momentum & Technical while CAPR counters with relative strength in Valuation, Options & Structure. Fundamentally, ERAS trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus CAPR at 78.7x Forward P/E and 0.0% operating margin (-7.9% YoY). In options structure, ERAS sits in BREAKDOWN (13th %ile IV; Dealer Gamma Walls on Pro) against CAPR sits in CONSOLIDATION (89th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner CAPR
ERAS N/M vs CAPR 78.7x Fwd P/E
Growth & Margin Winner ERAS
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs -7.9%
Momentum & Technical Winner ERAS
1Y +488.4% vs +44.3% ยท 52W Pos 57% vs 15%
Options & Structure Winner CAPR
BREAKDOWN (13th %ile IV) vs CONSOLIDATION (89th %ile IV)
ERAS NASDAQ
Erasca, Inc. Common Stock
Pharmaceutical Preparations
$14.95
-4.57% 1D
Market Cap $5.5B
1M Return +11.61%
1Y Return +488.39%
Forward P/E N/M
Unified AI Score
36.9 / 100 SELL
Tech 15.0 Fund 47.0 Flow 70.0 Mom 64.0
CAPR NASDAQ
Capricor Therapeutics Inc
Pharmaceutical Preparations
$8.47
-11.12% 1D
Market Cap $595.4M
1M Return +26.23%
1Y Return +44.29%
Forward P/E 78.7x
Unified AI Score
28.0 / 100 SELL
Tech 50.0 Fund 37.0 Flow 68.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ERAS +488.39% CAPR +44.29% Spread: +441.6 pp (ERAS Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ERAS TTM Op. Margin: 0.0% CAPR TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ERAS vs CAPR. Trailing 12-month operating profitability (ERAS 0.0% vs CAPR 0.0%) and valuation multiples (ERAS N/M vs CAPR 78.7x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ERAS (6) vs CAPR (2)
Institutional Metric ERAS CAPR Criterion Row Winner
Market Capitalization Scale $5.5B $595.4M Larger Scale ERAS
Trailing P/E Ratio Valuation N/M 78.7x Lower Multiple CAPR
Forward P/E Ratio Valuation N/M 78.7x Lower Multiple CAPR
Revenue Growth (YoY) Growth +0.0% -7.9% Higher Growth ERAS
Operating Margin (TTM) Profitability 0.0% 0.0% Higher Margin Tie
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -48.7% -100.5% Higher ROE ERAS
52-Week Range Position Momentum 57% ($2โ€“$24) 15% ($3โ€“$40) Stronger Trend ERAS
Beta / 30D Volatility Risk Regime 2.31ฮฒ ยท 81% Vol 1.52ฮฒ ยท 152% Vol Lower Realized Risk ERAS
Unified Institutional Score Composite Signal 36.9 / 100 (SELL) 28.0 / 100 (SELL) Higher Composite ERAS

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ERAS vs CAPR Buy Guide
ERAS BREAKDOWN
87d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 13th %ile
IV Regime Compressed (<25th %ile)
Live ERAS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CAPR CONSOLIDATION
56d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 89th %ile
IV Regime Extreme (>80th %ile)
Live CAPR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ERAS nor CAPR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.